Michael Bell serves as the Chief Financial Officer at Guardant Health Inc., a leading precision oncology company focused on developing innovative blood tests for cancer detection and monitoring. With a robust background in finance and healthcare, Bell has been instrumental in guiding Guardant Health through significant growth and development since joining the company. Prior to his role at Guardant Health, Bell held various high-level financial positions, including Senior Vice President of Finance at Agilent Technologies, where he honed his skills in strategic financial planning and corporate development. At Guardant Health, Bell's responsibilities encompass overseeing the company's financial strategy, including budgeting, forecasting, and investor relations. Under his leadership, Guardant Health has successfully navigated the complexities of the healthcare industry, securing funding and partnerships that have propelled the company's mission forward. His strategic vision and financial acumen have been pivotal in driving the company's expansion and in bringing innovative cancer diagnostic solutions to the market. Bell's contributions have not only solidified Guardant Health's financial stability but have also supported its commitment to improving patient outcomes through advanced medical technology.